Literature DB >> 34135356

Proteomic analysis of chicken bone marrow-derived dendritic cells in response to an inactivated IBV + NDV poultry vaccine.

Robin H G A van den Biggelaar1, Larissa van der Maas2, Hugo D Meiring2, Jeroen L A Pennings3, Willem van Eden1, Victor P M G Rutten1,4, Christine A Jansen5,6.   

Abstract

Inactivated poultry vaccines are subject to routine potency testing for batch release, requiring large numbers of animals. The replacement of in vivo tests for cell-based alternatives can be facilitated by the identification of biomarkers for vaccine-induced immune responses. In this study, chicken bone marrow-derived dendritic cells were stimulated with an inactivated vaccine for infectious bronchitis virus and Newcastle disease virus, as well as inactivated infectious bronchitis virus only, and lipopolysaccharides as positive control, or left unstimulated for comparison with the stimulated samples. Next, the cells were lysed and subjected to proteomic analysis. Stimulation with the vaccine resulted in 66 differentially expressed proteins associated with mRNA translation, immune responses, lipid metabolism and the proteasome. For the eight most significantly upregulated proteins, mRNA expression levels were assessed. Markers that showed increased expression at both mRNA and protein levels included PLIN2 and PSMB1. Stimulation with infectious bronchitis virus only resulted in 25 differentially expressed proteins, which were mostly proteins containing Src homology 2 domains. Stimulation with lipopolysaccharides resulted in 118 differentially expressed proteins associated with dendritic cell maturation and antimicrobial activity. This study provides leads to a better understanding of the activation of dendritic cells by an inactivated poultry vaccine, and identified PLIN2 and PSMB1 as potential biomarkers for cell-based potency testing.

Entities:  

Year:  2021        PMID: 34135356     DOI: 10.1038/s41598-021-89810-3

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  48 in total

Review 1.  Replacement, reduction and refinement alternatives to animal use in vaccine potency measurement.

Authors:  Coenraad F M Hendriksen
Journal:  Expert Rev Vaccines       Date:  2009-03       Impact factor: 5.217

2.  The European Partnership for Alternative Approaches to Animal Testing (EPAA): promoting alternative methods in Europe and beyond.

Authors:  Gwenole Cozigou; Jonathan Crozier; Coenraad Hendriksen; Irene Manou; Tzutzuy Ramirez-Hernandez; Renate Weissenhorn
Journal:  J Am Assoc Lab Anim Sci       Date:  2015-03       Impact factor: 1.232

3.  Proteome Analysis Is a Valuable Tool to Monitor Antigen Expression during Upstream Processing of Whole-Cell Pertussis Vaccines.

Authors:  Bernard Metz; Marieke Hoonakker; Joost P Uittenbogaard; Michel Weyts; Geert P M Mommen; Hugo D Meiring; Wichard Tilstra; Jeroen L A Pennings; Leo A van der Pol; Betsy Kuipers; Arjen Sloots; Jan van den IJssel; Bas van de Waterbeemd; Arno van der Ark
Journal:  J Proteome Res       Date:  2016-12-23       Impact factor: 4.466

4.  In vitro marker gene expression analyses in human peripheral blood mononuclear cells: A tool to assess safety of influenza vaccines in humans.

Authors:  Eita Sasaki; Haruka Momose; Yuki Hiradate; Ken J Ishii; Takuo Mizukami; Isao Hamaguchi
Journal:  J Immunotoxicol       Date:  2018-12       Impact factor: 3.000

5.  Uptake of particulate antigens in a nonmammalian lung: phenotypic and functional characterization of avian respiratory phagocytes using bacterial or viral antigens.

Authors:  Eveline D de Geus; Christine A Jansen; Lonneke Vervelde
Journal:  J Immunol       Date:  2012-03-30       Impact factor: 5.422

6.  Generation and characterization of chicken bone marrow-derived dendritic cells.

Authors:  Zhiguang Wu; Lisa Rothwell; John R Young; Jim Kaufman; Colin Butter; Pete Kaiser
Journal:  Immunology       Date:  2009-05-15       Impact factor: 7.397

7.  Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans.

Authors:  Troy D Querec; Rama S Akondy; Eva K Lee; Weiping Cao; Helder I Nakaya; Dirk Teuwen; Ali Pirani; Kim Gernert; Jiusheng Deng; Bruz Marzolf; Kathleen Kennedy; Haiyan Wu; Soumaya Bennouna; Herold Oluoch; Joseph Miller; Ricardo Z Vencio; Mark Mulligan; Alan Aderem; Rafi Ahmed; Bali Pulendran
Journal:  Nat Immunol       Date:  2008-11-23       Impact factor: 25.606

8.  Establishment of a new quality control and vaccine safety test for influenza vaccines and adjuvants using gene expression profiling.

Authors:  Haruka Momose; Takuo Mizukami; Madoka Kuramitsu; Kazuya Takizawa; Atsuko Masumi; Kumiko Araki; Keiko Furuhata; Kazunari Yamaguchi; Isao Hamaguchi
Journal:  PLoS One       Date:  2015-04-24       Impact factor: 3.240

Review 9.  New developments and concepts related to biomarker application to vaccines.

Authors:  S Sohail Ahmed; Steve Black; Jeffrey Ulmer
Journal:  Microb Biotechnol       Date:  2011-09-06       Impact factor: 5.813

10.  Vaccine-Mediated Activation of Human TLR4 Is Affected by Modulation of Culture Conditions during Whole-Cell Pertussis Vaccine Preparation.

Authors:  Marieke E Hoonakker; Lisa M Verhagen; Elder Pupo; Alex de Haan; Bernard Metz; Coenraad F M Hendriksen; Wanda G H Han; Arjen Sloots
Journal:  PLoS One       Date:  2016-08-22       Impact factor: 3.240

View more
  2 in total

Review 1.  Avian Cell Culture Models to Study Immunomodulatory Properties of Bioactive Products.

Authors:  Michelle Paradowska; Aleksandra Dunislawska; Maria Siwek; Anna Slawinska
Journal:  Animals (Basel)       Date:  2022-03-07       Impact factor: 2.752

2.  Transcriptome and proteome analysis of innate immune responses to inactivated Leptospira and bivalent Leptospira vaccines in canine 030-D cells.

Authors:  Andreja Novak; Jeroen L A Pennings; Larissa van der Maas; Hugo D Meiring; Irene Ludwig; Saertje Verkoeijen; Victor Rutten; Femke Broere; Arjen Sloots
Journal:  Sci Rep       Date:  2022-08-04       Impact factor: 4.996

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.